Alogliptin, a potent and selective dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes.

Carolyn F Deacon

37 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Alogliptin, a potent and selective dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes.'. Together they form a unique fingerprint.

Medicine & Life Sciences